[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Expression of estrogen receptor β isoforms in normal breast epithelial cells and breast cancer: regulation by methylation

Oncogene volume 22, pages 7600–7606 (2003)Cite this article

Abstract

Two novel estrogen receptor β (ERβ) mRNA isoforms that diverge in their 5′-untranslated regions, ERβ mRNA (0K-1) and ERβ mRNA (0N-1), have recently been identified. This indicates that transcription of the human ERβ gene occurs from at least two different promoters, named promoter 0K and promoter 0N. The aim of this study was to investigate the expression of ERβ isoforms in primary cultures of normal breast epithelial cells, a panel of breast cancer cell lines and in normal breast and breast cancer tissues; and to examine whether methylation of the two ERβ promoters is involved in regulation of ERβ gene expression. Using quantitative real-time PCR techniques, we found that ERβ mRNA levels were significantly lower in breast cancer cell lines than in primary cultures of normal breast epithelial cells. Bisulfite genomic sequencing analysis revealed that two promoters of the ERβ gene exhibit distinct methylation patterns. Promoter 0N was unmethylated in normal breast epithelial cells, but extensively methylated in breast cancer cell lines. In contrast, promoter 0K was unmethylated in both normal and malignant breast epithelial cells. We demonstrated a significant correlation between promoter 0N hypermethylation and loss of ERβ mRNA expression in breast cancer cell lines. Treatment of breast cancer cells with demethylating agent effectively reactivated the expression of ERβ mRNA. The observations from the cell lines were also reflected in primary breast cancer tumors. Thus, expression of ERβ mRNA in breast tumors was found to be inversely associated with the degree of methylation of promoter 0N. Our results suggest that a decreased level of ERβ mRNA may be associated with breast tumorigenesis, and that DNA methylation is an important mechanism for ERβ gene silencing in breast cancer.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Bieche I, Parfait B, Laurendeau I, Girault I, Vidaud M and Lidereau R . (2001). Oncogene, 20, 8109–8115.

  • Dotzlaw H, Leygue E, Watson PH and Murphy LC . (1999). Cancer Res., 59, 529–532.

  • Flouriot G, Griffin C, Kenealy M, Sonntag-Buck V and Gannon F . (1998). Mol. Endocrinol., 12, 1939–1954.

  • Fuqua SA, Schiff R, Parra I, Friedrichs WE, Su JL, McKee DD, Slentz-Kesler K, Moore LB, Willson TM and Moore JT . (1999). Cancer Res., 59, 5425–5428.

  • Gardiner-Garden M and Frommer M . (1987). J. Mol. Biol., 196, 261–282.

  • Garinis GA, Patrinos GP, Spanakis NE and Menounos PG . (2002). Hum. Genet., 111, 115–127.

  • Gomm JJ, Browne PJ, Coope RC, Liu QY, Buluwela L and Coombes RC . (1995). Anal. Biochem., 226, 91–99.

  • Gustafsson JA and Warner M . (2000). J. Steroid Biochem. Mol. Biol., 74, 245–248.

  • Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB . (1996). Proc. Natl. Acad. Sci. USA, 93, 9821–9826.

  • Hirata S, Shoda T, Kato J and Hoshi K . (2001). J. Steroid Biochem. Mol. Biol., 78, 33–40.

  • Iwao K, Miyoshi Y, Egawa C, Ikeda N and Noguchi S . (2000a). Int. J. Cancer, 88, 733–736.

  • Iwao K, Miyoshi Y, Egawa C, Ikeda N, Tsukamoto F and Noguchi S . (2000b). Cancer, 89, 1732–1738.

  • Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J and Wolffe AP . (1998). Nat. Genet., 19, 187–191.

  • Karpf AR and Jones DA . (2002). Oncogene, 21, 5496–5503.

  • Kokura K, Kaul SC, Wadhwa R, Nomura T, Khan MM, Shinagawa T, Yasukawa T, Colmenares C and Ishii S . (2001). J. Biol. Chem., 276, 34115–34121.

  • Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S and Gustafsson JA . (1996). Proc. Natl. Acad. Sci. USA, 93, 5925–5930.

  • Lewandowski S, Kalita K and Kaczmarek L . (2002). FEBS Lett., 524, 1–5.

  • Leygue E, Dotzlaw H, Watson PH and Murphy LC . (1998). Cancer Res., 58, 3197–3201.

  • Leygue E, Dotzlaw H, Watson PH and Murphy LC . (1999). Cancer Res., 59, 1175–1179.

  • Li LC, Yeh CC, Nojima D and Dahiya R . (2000). Biochem. Biophys. Res. Commun., 275, 682–689.

  • Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P and Evans RM . (1995). Cell, 83, 835–839.

  • Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM and Willson TM . (1998). Biochem. Biophys. Res. Commun., 247, 75–78.

  • Nojima D, Li LC, Dharia A, Perinchery G, Ribeiro-Filho L, Yen TS and Dahiya R . (2001). Cancer, 92, 2076–2083.

  • Ogawa S, Inoue S, Watanabe T, Hiroi H, Orimo A, Hosoi T, Ouchi Y and Muramatsu M . (1998a). Biochem. Biophys. Res. Commun., 243, 122–126.

  • Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y and Muramatsu M . (1998b). Nucleic Acids Res., 26, 3505–3512.

  • Omoto Y, Kobayashi S, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, Gustafsson JA and Iwase H . (2002). Eur. J. Cancer, 38, 380–386.

  • Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Warri A, Weihua Z, Van Noorden S, Wahlstrom T, Coombes RC, Warner M and Gustafsson JA . (2002). Endocr. Relat. Cancer, 9, 1–13.

  • Sasaki M, Tanaka Y, Perinchery G, Dharia A, Kotcherguina I, Fujimoto S and Dahiya R . (2002). J. Natl. Cancer Inst., 94, 384–390.

  • Skliris GP, Carder PJ, Lansdown MR and Speirs V . (2001). Br. J. Cancer, 84, 1095–1098.

  • Tate PH and Bird AP . (1993). Curr. Opin. Genet. Dev., 3, 226–231.

  • Tong D, Schuster E, Seifert M, Czerwenka K, Leodolte S and Zeillinger R . (2002). Breast Cancer Res. Treat., 71, 249–255.

Download references

Acknowledgements

We thank Laki Buluwela for supplying one of the normal breast epithelial cell samples. This study was supported by grants from the Swedish Cancer Fund and from KaroBio AB.

Author information

Authors and Affiliations

  1. Department of Biosciences at Novum, Karolinska Institutet, Huddinge, S-14157, Sweden

    Chunyan Zhao, Eva Enmark, Jan-Åke Gustafsson & Karin Dahlman-Wright

  2. Department of Cancer Medicine, Cancer Research-UK labs and Section of Cancer Cell Biology, Imperial College, London, W12 0NN, UK

    Eric W-F Lam, Andrew Sunters, Manuela Tamburo De Bella & R Charles Coombes

Authors
  1. Chunyan Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric W-F Lam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew Sunters
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eva Enmark
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Manuela Tamburo De Bella
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R Charles Coombes
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jan-Åke Gustafsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Karin Dahlman-Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chunyan Zhao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, C., Lam, EF., Sunters, A. et al. Expression of estrogen receptor β isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Oncogene 22, 7600–7606 (2003). https://doi.org/10.1038/sj.onc.1207100

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207100

Keywords

This article is cited by

Search

Advanced search

Quick links